At‑home PHi screening to help you and your clinician make informed decisions.
Important Information:
- The PHI® test assesses prostate cancer risk and is not a diagnostic test.
- Results should be reviewed with a qualified healthcare provider.
- ProtateGuard does not diagnose disease or provide medical treatment.
- FDA approval applies to the Prostate Health Index (PHI) assay.
- Eligibility may vary based on clinical guidelines.
©
ProstateGuard. All rights reserved.
